Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency

Published:2011-01 Issue:4 Volume:48 Page:481-489
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Qu Hongchang,Magotti Paola,Ricklin Daniel,Wu Emilia L.,Kourtzelis Ioannis,Wu You-Qiang,Kaznessis Yiannis N.,Lambris John D.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference60 articles.

1. Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration;Anon.;Nat. Rev. Drug Discov.,2009

2. Optimized selective N-methylation of peptides on solid support;Biron;J. Pept. Sci.,2006

3. What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs?;Bohm;Angew. Chem. Int. Ed.,1996

4. Binding thermodynamics of statins to HMG-CoA reductase;Carbonell;Biochemistry,2005

5. Complement and humoral immunity;Carroll;Vaccine,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors;Journal of Biological Chemistry;2024-07

2. Complement‐targeted therapeutics: An emerging field enabled by academic drug discovery;American Journal of Hematology;2023-03-31

3. Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors;Nature Communications;2022-09-20

4. The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target;Immunological Reviews;2022-09-15

5. Compstatins: the dawn of clinical C3-targeted complement inhibition;Trends in Pharmacological Sciences;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3